KCNB1 encodes the voltage-gated potassium channel subunit Kv2.1, a major delayed-rectifier channel in cortical and hippocampal neurons.[1][2] Kv2.1 helps set action potential repolarization kinetics, firing adaptation, and the coupling between electrical activity and calcium entry.[1:1][3] Because these processes are central to excitotoxic stress and synaptic vulnerability, KCNB1 is relevant to neurodegeneration even when it is not a primary monogenic cause.
| Property | Value |
|---|---|
| Gene Symbol | KCNB1 |
| Full Name | Potassium Voltage-Gated Channel Subfamily B Member 1 |
| Chromosomal Location | 20q13.13 |
| NCBI Gene ID | 3745 |
| Ensembl ID | ENSG00000158445 |
| UniProt ID | Q14721 |
Kv2.1 belongs to the Shab-related Kv2 family and contributes a large fraction of the delayed-rectifier K+ current in many projection neurons.[1:2][2:1] In mature neurons, Kv2.1 channels are frequently clustered on somatic and proximal dendritic membranes, where they shape repetitive firing and spike-frequency accommodation.[1:3][3:1]
Key functional roles include:
Under oxidative stress, Kv2.1 can undergo redox-dependent modification that alters channel behavior and has been linked to neurotoxic signaling cascades in experimental systems.[5][6]
Pathogenic de novo KCNB1 variants are established causes of developmental and epileptic encephalopathy, with variable combinations of seizures, developmental delay, and neurobehavioral phenotypes.[7][8] Many disease-associated variants reduce or alter channel function, though clinical severity varies across alleles.[7:1][8:1]
KCNB1 is not a canonical Mendelian Alzheimer's or Parkinson's gene, but several mechanisms are relevant to degenerative vulnerability:
Current evidence supports KCNB1 as a modifier pathway in neurodegeneration rather than a stand-alone disease driver.
Direct clinical biomarker assays for KCNB1 are not yet standardized. Near-term translational opportunities include:
Potential intervention logic is pathway-based:
At present, no KCNB1-specific neurodegeneration therapy has phase-III efficacy evidence.
Trimmer JS. Subcellular localization of K+ channels in mammalian brain neurons: remarkable precision in the midst of extraordinary complexity. Neuron. 2007. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Baranauskas G. Ionic channel function in action potential generation: current perspective. Mol Neurobiol. 2007. ↩︎ ↩︎ ↩︎
Misonou H, Mohapatra DP, Trimmer JS. Kv2.1: a voltage-gated K+ channel critical to dynamic control of neuronal excitability. Neurotoxicology. 2005. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Misonou H, Menegola M, Mohapatra DP, et al. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci. 2005. ↩︎ ↩︎ ↩︎
Cotella D, Hernandez-Enriquez B, Du Z, et al. Oxidation of KCNB1 potassium channels in the murine brain during aging is associated with cognitive impairment. Biochem Biophys Res Commun. 2019. ↩︎ ↩︎ ↩︎
Boscia F, D'Avanzo C, Pannaccione A, et al. Oxidation of KCNB1 potassium channels causes neurotoxicity and cognitive impairment in a mouse model of traumatic brain injury. J Neurosci. 2016. ↩︎ ↩︎ ↩︎
Torkamani A, Bersell K, Jorge BS, et al. De novo KCNB1 mutations in epileptic encephalopathy. Sci Rep. 2014. ↩︎ ↩︎
Xiong W, Li W, Wang Y, et al. Potassium channels and epilepsy. Acta Neurol Scand. 2022. ↩︎ ↩︎